Retractable Technologies (NYSE:RVP) Earns Hold Rating from Analysts at StockNews.com

StockNews.com began coverage on shares of Retractable Technologies (NYSE:RVP) in a research report report published on Thursday morning. The firm issued a hold rating on the stock.

Retractable Technologies Stock Down 1.9 %

Shares of NYSE:RVP opened at $1.06 on Thursday. Retractable Technologies has a 1 year low of $0.95 and a 1 year high of $1.85. The stock’s fifty day moving average price is $1.19 and its 200-day moving average price is $1.16. The company has a quick ratio of 6.41, a current ratio of 8.28 and a debt-to-equity ratio of 0.01.

Institutional Trading of Retractable Technologies

An institutional investor recently raised its position in Retractable Technologies stock. WealthTrust Axiom LLC boosted its stake in shares of Retractable Technologies, Inc. (NYSE:RVP) by 27.8% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 126,533 shares of the company’s stock after purchasing an additional 27,500 shares during the period. WealthTrust Axiom LLC owned about 0.42% of Retractable Technologies worth $151,000 at the end of the most recent reporting period. 7.58% of the stock is currently owned by institutional investors and hedge funds.

Retractable Technologies Company Profile

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.